PKM and neoplasm: Similar observations have been made by Goldberg and Sharp, who showed that targeting PKM2 with encapsulated siRNAs resulted in decreased cell viability and increased apoptosis in 10 members of the NCI-60 panel representing multiple types of cancer cell lines while having little effect in normal fibroblasts or endothelial cells and tumor regression in vivo mouse model [20].